Cargando…
Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice
Limb-girdle muscular dystrophy (MD) type 2B (LGMD2B) and Duchenne MD (DMD) are caused by mutations to the Dysferlin and Dystrophin genes, respectively. We have recently demonstrated in typically mild dysferlin- and dystrophin-deficient mouse models that increased plasma cholesterol levels severely e...
Autores principales: | White, Zoe, Sun, Zeren, Sauge, Elodie, Cox, Dan, Donen, Graham, Pechkovsky, Dmitri, Straub, Volker, Francis, Gordon A., Bernatchez, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706908/ https://www.ncbi.nlm.nih.gov/pubmed/36447272 http://dx.doi.org/10.1186/s13395-022-00308-6 |
Ejemplares similares
-
Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B
por: White, Zoe, et al.
Publicado: (2019) -
The Classification, Natural History and Treatment of the Limb Girdle Muscular Dystrophies
por: Murphy, Alexander Peter, et al.
Publicado: (2015) -
New aspects on patients affected by dysferlin deficient muscular dystrophy
por: Klinge, Lars, et al.
Publicado: (2009) -
Limb–Girdle Muscular Dystrophies Classification and Therapies
por: Bouchard, Camille, et al.
Publicado: (2023) -
Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations
por: Cacciottolo, Mafalda, et al.
Publicado: (2011)